Clinical Trials List
Protocol NumberNP30179
Completed
2019-02-01 - 2022-12-31
Phase I/II
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- - - 無
- 林建廷 Division of General Internal Medicine
- Huai-Hsuan Huang Division of General Internal Medicine
- Jih-Luh Tang Division of General Internal Medicine
- Chieh-Lung Cheng Division of General Internal Medicine
- 田豐銘 Division of General Internal Medicine
- MING YAO Division of General Internal Medicine
- CHENG-HONG TSAI Division of General Internal Medicine
- 吳茲皓 Division of General Internal Medicine
- Tai-Chung Huang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ching-Chan Lin Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Ming-Hung Tsai Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
485 participants
